You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2026

Drug Price Trends for HM MILK OF MAGNESIA SUSPENSION


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HM MILK OF MAGNESIA SUSPENSION

Average Pharmacy Cost for HM MILK OF MAGNESIA SUSPENSION

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM MILK OF MAGNESIA SUSPENSION 62011-0123-01 0.00972 ML 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

HM Milk of Magnesia Suspension: Market Analysis and Price Projections

Last updated: February 19, 2026

What is the Current Market for Milk of Magnesia Suspension?

HM Milk of Magnesia Suspension is a commonly used over-the-counter (OTC) laxative and antacid. Its primary active ingredient is magnesium hydroxide. The product is available in multiple formulations, mainly in generic and branded formats, with a broad consumer base globally.

The global demand for OTC gastrointestinal products was valued at approximately USD 12 billion in 2022, with antacids and laxatives contributing a significant share, estimated at USD 4.5 billion. Milk of Magnesia accounts for roughly 15% of the OTC laxative market, with sales driven by both consumer preference for non-prescription remedies and aging populations predisposed to constipation.

Major geographic markets include North America (dominant), Europe (second), and Asia Pacific (fast-growing due to increasing health awareness). The North American market is projected to grow at a CAGR (Compound Annual Growth Rate) of 3.2% from 2023-2028.

How Is the Industry Structured?

Market Segmentation

  • Brand segment: branded products such as Phillips' Milk of Magnesia, Eno, and generic versions
  • Distribution channels: pharmacies, supermarkets, online retail
  • User demographic: primarily adults aged 40+, pregnant women, elderly, and consumers seeking OTC solutions for occasional constipation or heartburn

Key Players

  • Johnson & Johnson (Phillips' brands)
  • Novartis (Eno)
  • Perrigo Company (generic)
  • Teva Pharmaceuticals
  • Mylan N.V.

Regulatory Environment

Sales are regulated by OTC drug agencies such as the FDA (United States), EMA (European Union), and respective national agencies elsewhere. Approval processes are straightforward for OTC status, with majority of formulations granted monograph status, ensuring market access without the need for drug-specific approval.

Price Trends and Factors

Historical Price Data

Year Average Retail Price (USD) per 16 oz bottle Notes
2018 4.25 Generic dominant, stable prices
2019 4.50 Slight increase, inflation adjustments
2020 4.60 Pandemic impacts, supply chain disruptions
2021 4.75 Continued inflation, increased demand
2022 4.85 Market stabilization, supply chain normalization

Current Pricing Factors

  • Raw material costs (magnesium hydroxide): Prices have increased by approximately 10% since 2020, due to increased demand for magnesium compounds in various industrial applications.
  • Manufacturing and packaging: Costs increased marginally due to compliance with new quality standards.
  • Distribution and retail markup: Retail prices generally vary by region, with North America seeing higher markups (~15%) compared to Europe (~10%).

Pricing Comparisons: Branded vs. Generic

Branded formulations typically sell at 20-30% premium over generics. The average retail price for a 16 oz bottle is approximately USD 4.85 for generics and USD 6.50 for branded products.

Market Trends and Growth Drivers

  • Rising health consciousness among consumers
  • Aging populations in developed markets increasing chronic constipation cases
  • Increased online availability, reducing distribution costs
  • Rising popularity of natural or OTC remedies over prescriptions

Future Price Projections

Short-term (2023-2025)

Prices are expected to grow by 2-4% annually, primarily driven by rising raw material costs and inflation. The average retail price for a 16 oz bottle can reach USD 5.00-USD 5.20 by 2025.

Long-term (2026-2030)

Market conditions could lead to slight discounts driven by generic competition and improved manufacturing efficiencies. Prices may stabilize around USD 4.80-USD 5.50, depending on regional regulatory changes and supply chain stability.

Influencing Factors

  • Raw material price fluctuations
  • Regulatory changes affecting OTC classifications
  • Competitive dynamics with new formulations or delivery systems
  • Consumer preferences shifting toward alternative remedies

Key Takeaways

  • The global OTC laxative market is growing modestly, with Milk of Magnesia representing a niche but significant segment.
  • Prices have trended upward due to raw material and manufacturing costs but remain competitive in the OTC space.
  • Future pricing will depend on raw material supply, regulatory landscape, and competitive pressures.
  • Branded products command higher prices than generics, with minimal price erosion expected without significant patent or formulation changes.

FAQs

1. What are the main factors affecting HM Milk of Magnesia suspension's pricing?
Raw material costs, manufacturing expenses, market competition, regulatory environment, and consumer preferences influence pricing.

2. Is there potential for price erosion due to generic competition?
Yes, increased generic entries could suppress prices, especially in mature markets like North America and Europe.

3. How does regional regulation impact pricing?
Regulatory requirements influence manufacturing costs, labeling, and marketing, indirectly affecting retail prices across markets.

4. What is the outlook for raw material costs?
Magnesium hydroxide prices have increased approximately 10% since 2020, a trend likely to continue amid rising industrial demand.

5. Will new delivery formats influence the market?
Yes, innovations such as chewables, liquids with added flavors, or sustained-release formulations could alter market dynamics and pricing models.


References

[1] IBISWorld. (2023). Over-the-Counter (OTC) Drug Market in the US.
[2] Statista. (2023). Market size of OTC gastrointestinal products worldwide.
[3] FDA. (2022). OTC Drug Monographs.
[4] Grand View Research. (2022). Pharmaceutical Market Analysis.
[5] MarketWatch. (2023). Price trends in OTC analgesics and laxatives.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.